Clinical Assessment, Neuroimaging and Immunomarkers in Chagas Disease Study (CLINICS)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 500 participants.
Also called NCT01650792
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 500 participants
- Registry
-
NCT01650792
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Brazil
- Registry status
- Unknown status
Technical summary
Registry record NCT01650792. Randomized; single masking; primary purpose treatment. Start 2012-07 (actual); primary completion 2024-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Assessment, Neuroimaging and Immunomarkers in Chagas Disease Study (CLINICS)
- Acronym
- CLINICS
- Condition
- Chagas Disease With Heart Failure
- Intervention (Drug)
- Aspirin
- Lead sponsor
- Federal University of Bahia
- Collaborator
- National Institutes of Health (NIH)
- Collaborator
- National Institute of Neurological Disorders and Stroke (NINDS)
Record details
- Record id
cardio:ct-nct01650792- Content hash
6fda4154a68f00cfb87cd79f3415cd71c8dd23b4570f8d8bd923c3c60e2d48bb